tocilizumab therapy | before | after |
---|---|---|
lymphadenopathy | yes | no |
hepatosplenomegaly | yes (severe) | mild |
autoimmune pancytopenia | yes | no |
myositis | worse | better |
alopecia | yes | better |
WBC (×109/L) | 0.90–1.36# 0.9–6.8## | 4.7–8.3### |
HB g/L | 87–106# 46–139## | 112–139### |
PLT (×109/L) | 32–51# 32–123## | 107–178### |
IgM | 1.84 | 0.62 |
IgA | 1.3 | 0.25 |
IgG | 14.5 | 6.6 a |
IgE | < 2 | < 2 |
CD3 | 89.13% (607) | 82.87% (786) |
CD4 | 32.41% (221) | 30.61% (290) |
CD8 | 51.17% (349) | 48.70% (462) |
CD4/CD8 | 0.63 | 0.63 |
CD19 | 8.74% (60) | 9.08% (31) |
NK | 1.49% (10) | 7.28% (69) |